share_log

艾美疫苗:(經修訂) 截至二零二四年二月二十九日止之股份發行人的證券變動月報表

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Hong Kong Stock Exchange ·  May 7 16:53
Summary by Futu AI
艾美疫苗股份有限公司於2024年5月7日重新提交了截至2024年2月29日的證券變動月報表。報告顯示,公司的H股和內資股在2月份均無增減,H股結存為492,173,711股,內資股結存為718,888,888股,股份期權計劃下的可發行股份數目亦無變動,維持在3,351,000股。艾美疫苗確認所有證券發行均獲得董事會批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
艾美疫苗股份有限公司於2024年5月7日重新提交了截至2024年2月29日的證券變動月報表。報告顯示,公司的H股和內資股在2月份均無增減,H股結存為492,173,711股,內資股結存為718,888,888股,股份期權計劃下的可發行股份數目亦無變動,維持在3,351,000股。艾美疫苗確認所有證券發行均獲得董事會批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
EMERY VACCINES CO., LTD. REFILED ON MAY 7, 2024 THE REPORT ON CHANGES IN SECURITIES FOR THE MONTH ENDED FEBRUARY 29, 2024. The report showed that the company's H shares and capital stock did not decrease in February, with 492,173,711 shares outstanding and 718,888,888 shares outstanding. The number of issuable shares under the share option plan remained unchanged at 3,351,000 shares. AMIE CONFIRMS THAT ALL SECURITIES ISSUANCES ARE APPROVED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
EMERY VACCINES CO., LTD. REFILED ON MAY 7, 2024 THE REPORT ON CHANGES IN SECURITIES FOR THE MONTH ENDED FEBRUARY 29, 2024. The report showed that the company's H shares and capital stock did not decrease in February, with 492,173,711 shares outstanding and 718,888,888 shares outstanding. The number of issuable shares under the share option plan remained unchanged at 3,351,000 shares. AMIE CONFIRMS THAT ALL SECURITIES ISSUANCES ARE APPROVED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.